Gregory Sargen
Vice President-Finance, Cambrex Corporation.
Companies
- Proteon TherapeuticsBoard member Jan 13, 2020 to now1
- Avid Bioservices, Inc.Board member Nov 29, 2017 to Feb 7, 20252
- Cambrex CorporationChief financial officer Jul 30, 2007 to Dec 5, 20193
- Cambrex CorporationVice President-Finance Jul 28, 2006 to Feb 4, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Avid Bioservices, Inc.0 shares5Feb 5, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 5, 2025Returned to company 36,368 shares of Avid Bioservices, Inc.5
- Dec 14, 2024Exercised options 26,756 shares of Avid Bioservices, Inc.6
- Dec 14, 2023Exercised options 9,612 shares of Avid Bioservices, Inc.7
- Apr 11, 2023Sold 7,011 shares at $20.24 of Avid Bioservices, Inc.8
- Dec 14, 2022Exercised options 4,632 shares of Avid Bioservices, Inc.9
- Dec 14, 2021Exercised options 2,379 shares of Avid Bioservices, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARProteon Therapeutics, Board member
- 2SEC EDGARAvid Bioservices, Inc., Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Dec 17, 2024
- 7SEC EDGARForm 4 filed Dec 18, 2023
- 8SEC EDGARForm 4 filed Apr 12, 2023
- 9SEC EDGARForm 4 filed Dec 16, 2022
- 10SEC EDGARForm 4 filed Dec 16, 2021